Original Research

Accepted on 21 May 2024

A Computed Tomography-based Nomogram for Neoadjuvant Chemotherapy Plus Immunotherapy Response Prediction in Patients with Advanced Esophageal Squamous Cell Carcinoma

Wen-Wen Guo
Chuanqinyuan Zhou
Dan Gao
Min Xu
Yan Gui
Haiying Zhou
Tian-wu Chen
Xiao-ming Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1358947

Review

Accepted on 21 May 2024

Progress in the study of antibody-drug conjugates for the treatment of cervical cancer

Congcong Zhai
Ling Guo
Cixiang Chen
Yili Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1395784

Systematic Review

Accepted on 21 May 2024

A bibliometric and Visualization analysis of research trends and hotspots on targeted therapy for breast cancer from 2003 to 2022

Deqi Wu
Chi Pan
Yangying Hu
Zhijie Shi
Yankun Zhou
Min Xiao

Frontiers in Oncology

doi 10.3389/fonc.2024.1366900

Review

Accepted on 21 May 2024

Hepatitis B Virus X Protein and TGF-β: Partners in the Carcinogenic Journey of Hepatocellular Carcinoma

Wei Yan
Rao Dean
Feimu Fan
Huifang Liang
Zunyi Zhang
Hanhua Dong

Frontiers in Oncology

doi 10.3389/fonc.2024.1407434

Original Research

Accepted on 21 May 2024

Anxiety and Depression in Patients with Non-Site-Specific Cancer Symptoms: Data from a Rapid Diagnostic Clinic

Maria Jose Monroy-Iglesias
Beth Russell
Sabine Martin
Louis Fox
Charlotte L Moss
Flaminia Bruno
Juliet Millwaters
Lindsay Steward
Colette Murtagh
Carlos Cargaleiro

Frontiers in Oncology

doi 10.3389/fonc.2024.1358888

Systematic Review

Accepted on 21 May 2024

Prognostic Relevance of Platelet Lymphocyte Ratio (PLR) in Gastric Cancer Patients Receiving Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis

树福 Hou
Dan dan Song
Yelei Zang
Ruiqi Hao
Linchuan Li
Jiankang Zhu

Frontiers in Oncology

doi 10.3389/fonc.2024.1367990

Brief Research Report

Accepted on 21 May 2024

Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real world, single center experience

Elisa Diral
Giulia Funari
Alessandro Bruno
Raffaella Greco
Daniela Clerici
Sarah Marktel
Francesca Farina
Sara Mastaglio
Luca Vago
Simona Piemontese

Frontiers in Oncology

doi 10.3389/fonc.2024.1391743

Original Research

Accepted on 21 May 2024

Construction of a novel nomogram for predicting overall survival (OS) in patients with Siewert type II AEG based on LODDS: a study based on the seer database and external validation

Xiaohan Yu
Chenglin Bai
Yang Yu
Xianzhan Guo
Kang Wang
Huimin Yang
Xiaodan Luan

Frontiers in Oncology

doi 10.3389/fonc.2024.1396339

Review

Accepted on 21 May 2024

Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review

Vahid Moradi
Elnaz Khodabandehloo
Mehdi Alidadi
Azadeh Omidkhoda
Naser Ahmadbeigi

Frontiers in Oncology

doi 10.3389/fonc.2024.1388475

Original Research

Accepted on 21 May 2024

Complete laparoscopic and Da Vinci robot esophagogastric anastomosis double muscle flap plasty for radical resection of proximal gastric cancer

Dong Yang
Yuanlin Liu
Xiangyu Meng
Xing Xu
Chao Wang
Meng Zhang
Tao Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1395549

Review

Accepted on 21 May 2024

CAR T-Cell for Aggressive Lymphomas Chimeric Antigen Receptor (CAR) T-Cell Therapy for Aggressive B Cell Lymphomas

Bei Hu
Victoria Korsos
M. Lia Palomba

Frontiers in Oncology

doi 10.3389/fonc.2024.1394057

Original Research

Accepted on 21 May 2024

Activation of Non-classical Wnt Signaling Pathway Effectively Enhances HLA-A Presentation in Acute Myeloid Leukemia

Yuhan Ma
Junshuai Yue
Ling Gao
Jingxin Zhou
Wei Chen
Jing Su
Jinrong Yao
Qiaomei Shi
Xiaodong Zhao
Na Hu

Frontiers in Oncology

doi 10.3389/fonc.2024.1336106

Editorial

Published on 21 May 2024

Editorial: Innovative molecular therapeutic approaches in urothelial carcinoma

Sheldon L. Holder
Ming Yin
Monika Joshi

Frontiers in Oncology

doi 10.3389/fonc.2024.1430285

Original Research

Published on 21 May 2024

Acute hematologic toxicity prediction using dosimetric and radiomics features in patients with cervical cancer: does the treatment regimen matter?

Haizhen Yue
Xiaofan Li
Jing You
Pujie Feng
Yi Du
Ruoxi Wang
Hao Wu
Jinsheng Cheng
Kuke Ding
Bin Jing

Frontiers in Oncology

doi 10.3389/fonc.2024.1365897

Original Research

Published on 21 May 2024

Detection and comparison of tumor cell-associated microbiota from different compartments of colorectal cancer

Yanzhen Zuo
Yanjie Lu
Jiayu Pang
Shunkang Jin
Xinyu Zhang
Enhong Zhao
Yuhong Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1374769

Original Research

Published on 21 May 2024

Physician preferences for nonmetastatic castration-resistant prostate cancer treatment in China

Yu Fan
Xuanjun Guo
Davide Campobasso
Zhisong He

Frontiers in Oncology

doi 10.3389/fonc.2024.1382678

Navigation group

Volumes

Volume 14 - 2024

A Computed Tomography-based Nomogram for Neoadjuvant Chemotherapy Plus Immunotherapy Response Prediction in Patients with Advanced Esophageal Squamous Cell Carcinoma

Progress in the study of antibody-drug conjugates for the treatment of cervical cancer

A bibliometric and Visualization analysis of research trends and hotspots on targeted therapy for breast cancer from 2003 to 2022

Hepatitis B Virus X Protein and TGF-β: Partners in the Carcinogenic Journey of Hepatocellular Carcinoma

Anxiety and Depression in Patients with Non-Site-Specific Cancer Symptoms: Data from a Rapid Diagnostic Clinic

Prognostic Relevance of Platelet Lymphocyte Ratio (PLR) in Gastric Cancer Patients Receiving Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis

Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real world, single center experience

Construction of a novel nomogram for predicting overall survival (OS) in patients with Siewert type II AEG based on LODDS: a study based on the seer database and external validation

Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review

Complete laparoscopic and Da Vinci robot esophagogastric anastomosis double muscle flap plasty for radical resection of proximal gastric cancer

CAR T-Cell for Aggressive Lymphomas Chimeric Antigen Receptor (CAR) T-Cell Therapy for Aggressive B Cell Lymphomas

Activation of Non-classical Wnt Signaling Pathway Effectively Enhances HLA-A Presentation in Acute Myeloid Leukemia

Editorial: Innovative molecular therapeutic approaches in urothelial carcinoma

Acute hematologic toxicity prediction using dosimetric and radiomics features in patients with cervical cancer: does the treatment regimen matter?

Detection and comparison of tumor cell-associated microbiota from different compartments of colorectal cancer

Physician preferences for nonmetastatic castration-resistant prostate cancer treatment in China